{
    "id": "24969508",
    "公司狀況": "解散\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t(110年08月10日\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t經授商字\r\n             \t\t\t\t\t\t\t\t\t\t\t\t\t第11001138730號)",
    "公司名稱": "新旭生技股份有限公司",
    "資本總額(元)": "1,000,000,000",
    "實收資本額(元)": "651,301,577",
    "代表人姓名": "",
    "公司所在地": "臺北市南港區園區街3號17樓",
    "登記機關": "經濟部商業司",
    "核准設立日期": {
        "year": 2015,
        "month": 5,
        "day": 20
    },
    "最後核准變更日期": {
        "year": 2021,
        "month": 8,
        "day": 10
    },
    "所營事業資料": [
        [
            "F601010",
            "智慧財產權業"
        ],
        [
            "IC01010",
            "藥品檢驗業"
        ],
        [
            "IG01010",
            "生物技術服務業"
        ],
        [
            "IG02010",
            "研究發展服務業"
        ]
    ],
    "董監事名單": [
        {
            "序號": "0007",
            "職稱": "監察人",
            "姓名": "林_美",
            "所代表法人": [
                0,
                "英屬開曼群島商 APRINOIA Therapeutics Inc."
            ],
            "出資額": "651,301,577"
        }
    ],
    "經理人名單": [],
    "股權狀況": "僑外資",
    "章程所訂外文公司名稱": "",
    "每股金額(元)": "1",
    "已發行股份總數(股)": "651,301,577"
}